4//SEC Filing
Pelish Henry E. 4
Accession 0001193125-25-240310
CIK 0001861560other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:30 PM ET
Size
32.1 KB
Accession
0001193125-25-240310
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Pelish Henry E.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-10-14$29.33/sh+825$24,197→ 68,396 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-13−4,168→ 21,528 totalExercise: $27.85Exp: 2033-01-06→ Class A Common Stock (4,168 underlying) - Sale
Class A Common Stock
2025-10-13$89.81/sh−7,637$685,879→ 65,963 total - Exercise/Conversion
Class A Common Stock
2025-10-14$18.93/sh+731$13,838→ 66,694 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-14−825→ 14,025 totalExercise: $29.33Exp: 2033-03-01→ Class A Common Stock (825 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-13$18.93/sh+1,669$31,594→ 67,632 total - Exercise/Conversion
Class A Common Stock
2025-10-14$27.85/sh+877$24,424→ 67,571 total - Sale
Class A Common Stock
2025-10-14$84.98/sh−1,167$99,172→ 67,229 total - Sale
Class A Common Stock
2025-10-14$87.39/sh−400$34,956→ 65,963 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-13−1,669→ 14,968 totalExercise: $18.93Exp: 2032-01-04→ Class A Common Stock (1,669 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-13$27.85/sh+4,168$116,079→ 71,800 total - Exercise/Conversion
Class A Common Stock
2025-10-13$72.35/sh+1,800$130,230→ 73,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-14−731→ 14,237 totalExercise: $18.93Exp: 2032-01-04→ Class A Common Stock (731 underlying) - Sale
Class A Common Stock
2025-10-14$86.11/sh−866$74,571→ 66,363 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-13−1,800→ 27,100 totalExercise: $72.35Exp: 2034-01-05→ Class A Common Stock (1,800 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-14−877→ 20,651 totalExercise: $27.85Exp: 2033-01-06→ Class A Common Stock (877 underlying)
Footnotes (9)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.80 to $89.83, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.64 to $85.63, inclusive.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.89 to $86.81, inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.33 to $87.56, inclusive.
- [F6]The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F7]The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F8]The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F9]The shares underlying this option have vested or shall vest over the four years following March 1, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0002029477
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:30 PM ET
- Size
- 32.1 KB